Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion type Assertion NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_head.
- NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion description "[Immunostaining of ATG5 in normal prostate cells was observed in 44.9% of the cases, whereas in prostate intraepithelial neoplasm (PIN) and prostate cancer cells, ATG5 was observed in 100% and 89.7% of the cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_provenance.
- NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion evidence source_evidence_literature NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_provenance.
- NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion SIO_000772 21995634 NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_provenance.
- NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion wasDerivedFrom befree-20150227 NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_provenance.
- NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_assertion wasGeneratedBy ECO_0000203 NP824528.RAPwvaTRkaW-PLnHzd5aLzFTOEDh9rVinw9TJMJtlirqw130_provenance.